| Source: |
| Type: |
| Various antioxidants such as Nrf2, SODs, catalase, GPxs, PRDXs, and GSTs are altered in different cancers and have been linked to prognosis. Their overexpression can correlate with aggressive tumor behavior and resistance to treatment in many contexts. |
| 8274- | LE, | Research on the Antiaging Activity of Licorice Water Extract in Aging Mice via Antioxidation, Neuronal Protection, Gut Microbiota Restoration, and PI3K/AKT/mTOR Modulation |
| - | in-vivo, | Nor, | NA |
| 8277- | LE, | Oncopreventive and oncotherapeutic potential of licorice triterpenoid compound glycyrrhizin and its derivatives: Molecular insights |
| - | Review, | Var, | NA |
| 1791- | LEC, | Vegetable lecithins: A review of their compositional diversity, impact on lipid metabolism and potential in cardiometabolic disease prevention |
| - | Review, | Nor, | NA |
| 1793- | LEC, | Unmasking Sunflower Lecithin: Does Science Support the Claims? |
| - | Review, | Nor, | NA |
| 1796- | LEC, | A comprehensive review on pleiotropic effects and therapeutic potential of soy lecithin |
| - | Review, | Var, | NA |
| 8129- | LF, | Study on the Therapeutic Benefit on Lactoferrin in Patients with Colorectal Cancer Receiving Chemotherapy |
| - | Trial, | CRC, | NA |
| 8141- | LF, | Controversial role of lactoferrin in cancer: A narrative review |
| - | Review, | Var, | NA |
| 8201- | LGE, | Citral, a component of lemongrass oil inhibits the clastogenic effect of nickel chloride in mouse micronucleus test system |
| - | in-vivo, | Nor, | NA |
| 8205- | LGE, | Citral: Bioactivity, Metabolism, Delivery Systems, and Food Preservation Applications |
| - | Review, | Nor, | NA |
| 8203- | LGE, | Eug, | Citral and eugenol modulate DNA damage and pro-inflammatory mediator genes in murine peritoneal macrophages |
| - | in-vitro, | Nor, | NA |
| 8200- | LGE, | Chemical Properties and Therapeutic Potential of Citral, a Monoterpene Isolated from Lemongrass |
| - | Review, | Var, | NA |
| 8292- | lign, | Anticancer potential of flaxseed lignans, their metabolites and synthetic counterparts in relation with molecular targets: current challenges and future perspectives |
| - | Review, | Var, | NA |
| 8295- | lign, | Distribution, biosynthesis and therapeutic potential of lignans |
| - | Review, | Var, | NA |
| 8311- | lign, | The Power of Lignans: Plant Compounds with Multifaceted Health-Promoting Effects |
| - | Review, | Nor, | NA |
| 8320- | LIN, | Ameliorative Effect of Linalool in Cisplatin-Induced Nephrotoxicity: The Role of HMGB1/TLR4/NF-κB and Nrf2/HO1 Pathways |
| - | in-vivo, | Nor, | NA |
| 7825- | LT, | MBS, | Neuroprotective Potential of Mung Bean (Vigna radiata L.) Polyphenols in Alzheimer's Disease: A Review |
| - | Review, | AD, | NA |
| 8382- | LT, | Luteolin as a dietary flavonoid for brain health: modulating neuroinflammation and cognitive decline in neurodegenerative disorders |
| - | Review, | AD, | NA | - | Review, | Park, | NA |
| 8384- | LT, | Current situation and research progress of luteolin in the treatment of gastrointestinal malignant tumors |
| - | Review, | GC, | NA |
| 8390- | LT, | Luteolin in Inflammatory Bowel Disease and Colorectal Cancer: A Disease Continuum Perspective |
| - | Review, | IBD, | NA | - | Review, | CRC, | NA |
| 8403- | LT, | Luteolin induces apoptotic cell death via antioxidant activity in human colon cancer cells |
| - | in-vitro, | CRC, | HT-29 |
| 8398- | LT, | Luteolin: Nature's promising warrior against Alzheimer's and Parkinson's disease |
| - | Review, | AD, | NA | - | Review, | Park, | NA |
| 8367- | LT, | Role of Luteolin in Prevention of Oral, Esophageal, Gastric, Pancreatic, and Colon Cancers: Recent Trends and Future Perspectives |
| - | Review, | Var, | NA |
| 2930- | LT, | Luteolin confers renoprotection against ischemia–reperfusion injury via involving Nrf2 pathway and regulating miR320 |
| - | in-vitro, | Nor, | NA |
| 2921- | LT, | Luteolin as a potential hepatoprotective drug: Molecular mechanisms and treatment strategies |
| - | Review, | Nor, | NA |
| 2906- | LT, | Luteolin, a flavonoid with potentials for cancer prevention and therapy |
| - | Review, | Var, | NA |
| 2907- | LT, | Protective effect of luteolin against oxidative stress‑mediated cell injury via enhancing antioxidant systems |
| - | in-vitro, | Nor, | NA |
| 2914- | LT, | Therapeutic Potential of Luteolin on Cancer |
| - | Review, | Var, | NA |
| 2916- | LT, | Antioxidative and Anticancer Potential of Luteolin: A Comprehensive Approach Against Wide Range of Human Malignancies |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
| 4294- | LT, | Luteolin reduces zinc-induced tau phosphorylation at Ser262/356 in an ROS-dependent manner in SH-SY5Y cells |
| - | in-vitro, | AD, | SH-SY5Y |
| 4293- | LT, | Regulatory Role of NF-κB on HDAC2 and Tau Hyperphosphorylation in Diabetic Encephalopathy and the Therapeutic Potential of Luteolin |
| - | in-vivo, | Diabetic, | NA |
| 4292- | LT, | Luteolin for neurodegenerative diseases: a review |
| - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | MS, | NA | - | Review, | Stroke, | NA |
| 4231- | LT, | Luteolin and its antidepressant properties: From mechanism of action to potential therapeutic application |
| - | Review, | AD, | NA |
| 8349- | Lut, | Lutein Inhibits Cell Growth and Activates Apoptosis via the PI3K/AKT/mTOR Signaling Pathway in A549 Human Non-Small-Cell Lung Cancer Cells |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | HCC827 | - | in-vitro, | Nor, | BEAS-2B |
| 8343- | Lut, | Association of Lutein with Cancer: A Systematic Review of the Lutein Effects on Cellular Processes Involved in Cancer Progression |
| - | Review, | Var, | NA |
| 3533- | Lyco, | Chemo, | Lycopene and chemotherapy toxicity |
| - | Review, | Var, | NA |
| 3532- | Lyco, | Lycopene alleviates oxidative stress via the PI3K/Akt/Nrf2pathway in a cell model of Alzheimer’s disease |
| - | in-vitro, | AD, | NA |
| 3530- | Lyco, | Lycopene Scavenges Cellular ROS, Modulates Autophagy and Improves Survival through 7SK snRNA Interaction in Smooth Muscle Cells |
| - | in-vitro, | Stroke, | NA |
| 3529- | Lyco, | The antioxidant and anti-inflammatory properties of lycopene in mice lungs exposed to cigarette smoke |
| - | in-vivo, | Nor, | NA |
| 3528- | Lyco, | The Importance of Antioxidant Activity for the Health-Promoting Effect of Lycopene |
| - | Review, | Nor, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
| 3828- | Lyco, | Lycopene alleviates oxidative stress via the PI3K/Akt/Nrf2pathway in a cell model of Alzheimer's disease |
| - | in-vitro, | AD, | M146L |
| 3273- | Lyco, | Lycopene |
| - | Review, | Var, | NA |
| 3268- | Lyco, | Lycopene as a Natural Antioxidant Used to Prevent Human Health Disorders |
| - | Review, | AD, | NA |
| 3264- | Lyco, | Pharmacological potentials of lycopene against aging and aging‐related disorders: A review |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Stroke, | NA |
| 3261- | Lyco, | Lycopene and Vascular Health |
| - | Review, | Stroke, | NA |
| 3277- | Lyco, | Recent trends and advances in the epidemiology, synergism, and delivery system of lycopene as an anti-cancer agent |
| - | Review, | Var, | NA |
| 3280- | Lyco, | Lycopene as A Carotenoid Provides Radioprotectant and Antioxidant Effects by Quenching Radiation-Induced Free Radical Singlet Oxygen: An Overview |
| - | Review, | Var, | NA |
| 8421- | Lyco, | Lycopene: Sojourn from kitchen to an effective therapy in Alzheimer's disease |
| - | Review, | AD, | NA |
| 8419- | Lyco, | Brain-targeted lycopene-loaded microemulsion modulates neuroinflammation, oxidative stress, apoptosis and synaptic plasticity in β-amyloid-induced Alzheimer’s disease mice |
| - | in-vivo, | AD, | NA |
| 8412- | Lyco, | Brain-targeted lycopene-loaded microemulsion modulates neuroinflammation, oxidative stress, apoptosis and synaptic plasticity in β-amyloid-induced Alzheimer's disease mice |
| - | in-vivo, | AD, | NA |
| 8411- | Lyco, | Lycopene destabilizes preformed Aβ fibrils: Mechanistic insights from all-atom molecular dynamics simulation |
| - | Study, | AD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1103 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid